Société Neuropathix, Inc.
Actions
NPTX
US64132Q1094
Recherche biotechnologique et médicale
Métier
Nombre d'employés: 6
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Dean Petkanas
CEO | Chief Executive Officer | 60 | 25/07/18 |
Mark Corrao
DFI | Director of Finance/CFO | 67 | 25/07/18 |
William Kinney
CTO | Chief Tech/Sci/R&D Officer | 66 | 25/07/18 |
Robert Malasek
BRD | Director/Board Member | 55 | 20/06/17 |
Mark McDonnell
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Robert Malasek
BRD | Director/Board Member | 55 | 20/06/17 |
Timothy Scott
BRD | Director/Board Member | 71 | 25/07/18 |
Dean Petkanas
CEO | Chief Executive Officer | 60 | 25/07/18 |
Blake Schroeder
BRD | Director/Board Member | 48 | 25/07/18 |
Thomas Kikis
FOU | Founder | 46 | 25/07/18 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 93 810 559 | 71 724 607 ( 76,46 %) | 0 | 76,46 % |
Coordonnées société
Neuropathix, Inc.
Pennsylvania Biotechnology Center 3805 Old Easton Road
18902, Doylestown
+
http://www.neuropathix.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
-1,17% | 102 Md | |
+2,87% | 96,09 Md | |
+2,13% | 22,28 Md | |
-14,77% | 21,4 Md | |
-8,79% | 18,14 Md | |
-39,98% | 17,02 Md | |
-13,21% | 16,09 Md | |
+8,55% | 13,83 Md | |
+35,75% | 11,97 Md |